top of page

PUBLISHED PAPERS

GENERAL

BLOOD TRANSFUSION PUBLICATIONS

  • EBA Board adopts Position Paper on the labelling, coding and identification of blood, blood components, tissues and cells. At the Board Meeting in Valletta, Malta, the EBA Board has voted to support the universal use of the ISBT 128 for labelling, coding and identification of blood, blood components, tissues and cells. EBA Position Paper on Coding and Labeling – PDF (01 Oct 2010)
     

  • Guidelines for the use of RFID technology in transfusion medicine. Vox Sang (2010) 98:1-24. (Special Issue)
     

  • Ashford, P. Gullikson J, Georgsen, J and Distler, P.  Standard terminology for platelet additive solutions.  Vox Sang (2010) 98(4):577-578.
     

  • Ashford P. Fearon M., Bedford R.  Report on the joint IBEPAG/ICCBBA survey on import/export and blood component labeling. Vox Sang (2010) 98, 85–86.
     

  • Distler, PB. ISBT 128 An internationally standardized means to label cellular therapy products. Pharmaceuticals Policy and Law (2007) 9:421-430.

  • Ashford, P. ISBT 128: contributing to the safety of transfusion and transplantation. ISBT 128 Science Series (2007) 2:113-116.

  • Ashford P.  ISBT 128 – Improving Security by International Standardization. ISBT Science Series (1) 242-245 (2006).
     

  • Butch, SH. and Distler, PB. ISBT 128 blood labeling: introduction and reference laboratory applications. Immunohematology (2006): 22:30-35

  • Munk, Charles et al., ISBT 128: The Implementation Project of the Swiss Red Cross Blood Transfusion Service. ISBT Congress Proceeding, Journal of Blood Banks, and Transfusion Society of Turkey, July (2003)

CELLULAR THERAPY PUBLICATIONS

  • Boğa C, Maytalman E, Gereklioğlu Ç, Asma S, Kandemir F, Aytan P, Korur A, Yeral M, Kozanoğlu İ, Özdoğu H. Implementation of an ISBT 128-Compatible Medical Record System to Facilitate Traceability of Stem Cells. Turk J Haematol. 2017 Aug 2;34(3):280-281. doi: 10.4274/tjh.2017.0081. Epub 2017 Apr 26.PMID: 28443818

  • Slaper-Cortenbach, Ineke; ISBT 128 coding and labeling for cellular therapy products. Cell and Tissue Banking (2010). 
     

  • Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; Terminology and labeling of cellular products: 1. Standards. Bone marrow transplantation 2007;40(11):1075-83.
     

  • Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; Terminology and labeling of cellular products 2: Implementation plan. Bone marrow transplantation 2007;40(11):1085-90.
     

  • Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; Standards for the terminology and labeling of cellular therapy products. Transfusion 2007;47(7):1319-27. (You must be a registered member with AABB to access this publication)
     

  • Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; ISBT 128 implementation plan for cellular therapy products. Transfusion 2007;47(7):1312-8.  (You must be a registered member with AABB to access this publication)
     

  • Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; ISBT 128 implementation plan for cellular therapy products. Journal of clinical apheresis 2007;22(5):258-64.
     

  • Ashford P; Distler P; Gee A; Lankester A; Larsson S: Feller I; Loper K; Pamphilon D; Poston L; Rabe F; Slaper-Cortenbach I; Szczepiorkowski Z; Warkentin P; Standards for the terminology and labeling of cellular therapy products. Journal of clinical apheresis 2007;22(5):249-57.

MEDICAL DEVICE PUBLICATIONS

OCULAR PUBLICATIONS

TISSUE PUBLICATIONS

REPRODUCTIVE PUBLICATIONS

NEWSLETTERS

GRAPHIC PRESENTATIONS
bottom of page